(Q46727522)

English

Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

adaptive radiation therapy

0 references

Lisa M DeAngelis

object named as

Lisa DeAngelis

4

0 references

author name string

Barbara Fisher

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

Wendy Seiferheld

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

Christopher Schultz

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

Diane Nelson

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

S C Schold

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

W Curran

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

M Mehta

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

74

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

201-205

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16193393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time-dependent tumour repopulation factors in linear-quadratic equations--implications for treatment strategies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16193393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16193393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined modality therapy for primary CNS lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16193393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315

1 reference

https://pubmed.ncbi.nlm.nih.gov/16193393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16193393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16193393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16193393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review: total doses in fractionated radiotherapy--implications of new radiobiological data

1 reference

https://pubmed.ncbi.nlm.nih.gov/16193393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://pubmed.ncbi.nlm.nih.gov/16193393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of primary central nervous system lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16193393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments

1 reference

https://pubmed.ncbi.nlm.nih.gov/16193393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-004-6596-9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16193393

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46727522&oldid=2208050401"